These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 37081402

  • 1. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
    Zhang Z, Wang J, Han W, Zhao L.
    BMC Gastroenterol; 2023 Apr 20; 23(1):132. PubMed ID: 37081402
    [Abstract] [Full Text] [Related]

  • 2. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W, Liu J, Zhao H.
    Aging (Albany NY); 2020 Jan 24; 12(2):1512-1526. PubMed ID: 31978896
    [Abstract] [Full Text] [Related]

  • 3. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma.
    Zhao F, Li Z, Dong Z, Wang Z, Guo P, Zhang D, Li S.
    Front Immunol; 2022 Jan 24; 13():918154. PubMed ID: 35880180
    [Abstract] [Full Text] [Related]

  • 4. Identification of m5C-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients.
    Ma Y, Sun Y, Zhao X, Li J, Fu X, Gong T, Zhang X.
    Sci Rep; 2023 Sep 04; 13(1):14499. PubMed ID: 37666951
    [Abstract] [Full Text] [Related]

  • 5. Identification of Epithelial-Mesenchymal Transition- (EMT-) Related LncRNA for Prognostic Prediction and Risk Stratification in Esophageal Squamous Cell Carcinoma.
    Wang P, Chen Y, Zheng Y, Fu Y, Ding Z.
    Dis Markers; 2021 Sep 04; 2021():5340240. PubMed ID: 34712369
    [Abstract] [Full Text] [Related]

  • 6. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
    Xiong X, Chen C, Li X, Yang J, Zhang W, Wang X, Zhang H, Peng M, Li L, Luo P.
    Front Oncol; 2023 Sep 04; 13():972558. PubMed ID: 37064115
    [Abstract] [Full Text] [Related]

  • 7. Identification and validation of an eight-lncRNA signature that predicts prognosis in patients with esophageal squamous cell carcinoma.
    Zhang J, Ling X, Fang C, Ma J.
    Cell Mol Biol Lett; 2022 May 16; 27(1):39. PubMed ID: 35578166
    [Abstract] [Full Text] [Related]

  • 8. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
    Huang Y, Gong P, Su L, Zhang M.
    Sci Rep; 2023 Nov 27; 13(1):20870. PubMed ID: 38012210
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W, Ye Z, Chen L, Liang H, Cai Q.
    Int Immunopharmacol; 2021 Dec 27; 101(Pt B):108268. PubMed ID: 34688154
    [Abstract] [Full Text] [Related]

  • 11. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W, Tan F, Huai Q, Wang Z, Shao F, Zhang G, Yang Z, Li R, Xue Q, Gao S, He J.
    Front Immunol; 2021 Dec 27; 12():669750. PubMed ID: 34054840
    [Abstract] [Full Text] [Related]

  • 12. A Novel Prognostic Chemokine-Related lncRNAs Signature Associated with Immune Landscape in Colon Adenocarcinoma.
    Dai X, Zeng M, Huang Z, Zhang J, Wei Z, Wang Z.
    Dis Markers; 2022 Dec 27; 2022():2823042. PubMed ID: 36393968
    [Abstract] [Full Text] [Related]

  • 13. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma.
    Ma C, Luo H.
    Clin Res Hepatol Gastroenterol; 2022 Dec 27; 46(10):102033. PubMed ID: 36265781
    [Abstract] [Full Text] [Related]

  • 14. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW, Xue YJ, Wu ZY, Xu XE, Wu JY, Cao HH, Zhu Y, He JZ, Li CQ, Li EM, Xu LY.
    BMC Cancer; 2018 Feb 06; 18(1):147. PubMed ID: 29409459
    [Abstract] [Full Text] [Related]

  • 15. The prognostic value of a seven-lncRNA signature in patients with esophageal squamous cell carcinoma: a lncRNA expression analysis.
    Weng NQ, Chi J, Wen J, Mai SJ, Zhang MY, Huang L, Liu J, Yang XZ, Xu GL, Fu JH, Wang HY.
    J Transl Med; 2020 Jan 31; 18(1):47. PubMed ID: 32005248
    [Abstract] [Full Text] [Related]

  • 16. Predicting the Immune Microenvironment and Prognosis with a NETosis-Related lncRNA Signature in Head and Neck Squamous Cell Carcinoma.
    He X, Xiao Y, Liu S, Deng R, Li Z, Zhu X.
    Biomed Res Int; 2022 Jan 31; 2022():3191474. PubMed ID: 36147630
    [Abstract] [Full Text] [Related]

  • 17. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma.
    Xu Z, Li X, Pan L, Tan R, Ji P, Tang H.
    J Oral Pathol Med; 2022 Apr 31; 51(4):358-368. PubMed ID: 35100473
    [Abstract] [Full Text] [Related]

  • 18. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q, Zhang P, Zhang X, Feng Y, Li L, Lin H, Yu Y.
    Front Immunol; 2023 Apr 31; 14():1199040. PubMed ID: 37313409
    [Abstract] [Full Text] [Related]

  • 19. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
    Pan J, Huang Z, Lin H, Cheng W, Lai J, Li J.
    BMC Cancer; 2022 Nov 04; 22(1):1132. PubMed ID: 36333719
    [Abstract] [Full Text] [Related]

  • 20. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
    Song Z, Su M, Li X, Xie J, Han F, Yao J.
    BMC Gastroenterol; 2023 Dec 09; 23(1):432. PubMed ID: 38066437
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.